Annual report
4588.TEDINET S100PNC1
Period2020-01-01 → 2020-12-31
Filed2022-11-17
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Amends S100L1LQ.
Key figures · 78
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥314m | 2020-01-01 → 2020-12-31 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2019-01-01 → 2019-12-31 | Standalone | Net sales |
| Revenue | ¥169m | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥229m | 2017-01-01 → 2017-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥178m | 2016-01-01 → 2016-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥1.7bn | 2020-01-01 → 2020-12-31 | Standalone | Operating income |
| Operating income | −¥511m | 2019-01-01 → 2019-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.7bn | 2020-01-01 → 2020-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥539m | 2019-01-01 → 2019-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.2bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2017-01-01 → 2017-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥864m | 2016-01-01 → 2016-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥2.1bn | 2020-01-01 → 2020-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥909m | 2019-01-01 → 2019-12-31 | Standalone | Income before income taxes |
| Net income | −¥2.1bn | 2020-01-01 → 2020-12-31 | Standalone | Profit loss |
| Net income | −¥912m | 2019-01-01 → 2019-12-31 | Standalone | Profit loss |
| Net income | −¥1.2bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.1bn | 2017-01-01 → 2017-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥931m | 2016-01-01 → 2016-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.8bn | at 2020-12-31 | Standalone | Assets |
| Total assets | ¥4.4bn | at 2019-12-31 | Standalone | Assets |
| Total assets | ¥3.4bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2017-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2016-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥793m | at 2020-12-31 | Standalone | Liabilities |
| Total liabilities | ¥926m | at 2019-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2020-12-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2019-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2018-12-31d | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2017-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.6bn | at 2016-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2020-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2019-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2020-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2019-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2018-12-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2017-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.4bn | at 2016-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.5bn | 2020-01-01 → 2020-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥238m | 2019-01-01 → 2019-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2017-01-01 → 2017-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥903m | 2016-01-01 → 2016-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥38m | 2020-01-01 → 2020-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥4m | 2019-01-01 → 2019-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥342m | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥132m | 2017-01-01 → 2017-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥257m | 2016-01-01 → 2016-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥242m | 2020-01-01 → 2020-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2019-01-01 → 2019-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2017-01-01 → 2017-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6m | 2016-01-01 → 2016-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-145.58 | 2020-01-01 → 2020-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-65.55 | 2019-01-01 → 2019-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-104.55 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-106.23 | 2017-01-01 → 2017-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-101.18 | 2016-01-01 → 2016-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥136.43 | at 2020-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥240.71 | at 2019-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥216.61 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥263.54 | at 2017-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥283.43 | at 2016-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.4% | at 2020-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2019-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.3% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.9% | at 2017-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.7% | at 2016-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 14,641,900 | at 2020-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,331,300 | at 2019-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,346,000 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,086,000 | at 2017-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,234,600 | at 2016-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 32 | at 2020-12-31 | Standalone | Number of employees |
| Employees | 27 | at 2019-12-31 | Standalone | Number of employees |
| Employees | 30 | at 2018-12-31d | Standalone | Number of employees |
| Employees | 29 | at 2017-12-31d | Standalone | Number of employees |
| Employees | 30 | at 2016-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2020-01-01 → 2020-12-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2020-01-01 → 2020-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2020-12-31 | ¥2.7bn |
| Reconciling Itemsreconciling | segment profit | 2020-01-01 → 2020-12-31 | −¥888m |
| Diagnostic Divisionreportable segment | capex | 2020-01-01 → 2020-12-31 | ¥14m |
| Diagnostic Divisionreportable segment | depreciation | 2020-01-01 → 2020-12-31 | ¥2m |
| Diagnostic Divisionreportable segment | employees | at 2020-12-31 | 2 pure |
| Diagnostic Divisionreportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥610,000 |
| Diagnostic Divisionreportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥610,000 |
| Diagnostic Divisionreportable segment | segment assets | at 2020-12-31 | ¥22m |
| Diagnostic Divisionreportable segment | segment profit | 2020-01-01 → 2020-12-31 | −¥73m |
| Pharmaceutical Divisionreportable segment | employees | at 2020-12-31 | 12 pure |
| Pharmaceutical Divisionreportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥314m |
| Pharmaceutical Divisionreportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥314m |
| Pharmaceutical Divisionreportable segment | segment assets | at 2020-12-31 | ¥91m |
| Pharmaceutical Divisionreportable segment | segment profit | 2020-01-01 → 2020-12-31 | −¥713m |
| —segment total | employees | at 2020-12-31 | 14 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-01-01 → 2020-12-31 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-01-01 → 2020-12-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-01-01 → 2020-12-31 | ¥314m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-01-01 → 2020-12-31 | ¥314m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2020-12-31 | ¥113m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-01-01 → 2020-12-31 | −¥787m |
| Reconciling Itemsreconciling | capex | 2019-01-01 → 2019-12-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2019-01-01 → 2019-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2019-12-31 | ¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2019-01-01 → 2019-12-31 | −¥733m |
| Diagnostic Divisionreportable segment | capex | 2019-01-01 → 2019-12-31 | ¥10m |
| Diagnostic Divisionreportable segment | depreciation | 2019-01-01 → 2019-12-31 | ¥303,000 |
| Diagnostic Divisionreportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥11m |
| Diagnostic Divisionreportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥11m |
| Diagnostic Divisionreportable segment | segment assets | at 2019-12-31 | ¥10m |
| Diagnostic Divisionreportable segment | segment profit | 2019-01-01 → 2019-12-31 | −¥152m |
| Pharmaceutical Divisionreportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Pharmaceutical Divisionreportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Pharmaceutical Divisionreportable segment | segment assets | at 2019-12-31 | ¥420m |
| Pharmaceutical Divisionreportable segment | segment profit | 2019-01-01 → 2019-12-31 | ¥373m |
| Total Of Reportable Segments And Otherssegment total | capex | 2019-01-01 → 2019-12-31 | ¥10m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2019-01-01 → 2019-12-31 | ¥303,000 |
| Total Of Reportable Segments And Otherssegment total | revenue | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2019-12-31 | ¥430m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2019-01-01 → 2019-12-31 | ¥221m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 952
| Item | Context | Value | Unit |
|---|---|---|---|
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Interim dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Interim dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Interim dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -101.18 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -106.23 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -104.55 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -65.55 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -145.58 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 0.827 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 0.829 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 0.8430 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.787 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.714 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -903424000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -1096840000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -1187579000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -238228000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -1465199000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 256627000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 131662000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 342040000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -4442000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -37577000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |